InvestorsHub Logo
Followers 41
Posts 5379
Boards Moderated 0
Alias Born 11/15/2013

Re: frenchbroad post# 398171

Thursday, 06/08/2023 8:15:46 PM

Thursday, June 08, 2023 8:15:46 PM

Post# of 402945
Per company pipeline-
Innovation Pharma owns rights to Brilacidin, a de novo-designed defensin-mimetic drug candidate exhibiting anti-inflammatory and antimicrobial properties. Brilacidin has been evaluated in multiple clinical trials (over 500 patients treated to date), received special FDA designations and can be administered via various modes of delivery.

Freedom is not free.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News